Pneumocystis pneumonia in a treatment-naive rheumatoid arthritis patient

Anuoluwapo Shobayo1, Chiemeziem Nwanyanwu1, Edward Chapnick1

  • 1The Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.

Idcases
|November 7, 2019
PubMed

Insights

Newly diagnosed rheumatoid arthritis patients can develop pneumocystis pneumonia, even without HIV. Early recognition and treatment are crucial for managing this opportunistic infection in rheumatoid arthritis (RA) patients.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Pulmonology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting joints.
  • Patients with RA may be immunocompromised due to the disease itself or its treatments.
  • Opportunistic infections are a known complication in immunocompromised individuals.

Observation:

  • A case study of a human immunodeficiency virus (HIV)-negative patient newly diagnosed with RA.
  • The patient presented with symptoms indicative of an infection.
  • Diagnostic tests confirmed the presence of *Pneumocystis jiroveci* pneumonia (PCP).

Findings:

  • The patient, despite being HIV-negative, developed PCP, a serious opportunistic infection.
  • Treatment involved a three-week course of atovaquone and corticosteroids.
  • The patient's RA was newly diagnosed and not yet undergoing immunosuppressive therapy.

Implications:

  • This case highlights that RA patients, irrespective of HIV status, are at risk for PCP.
  • Clinicians must maintain a high index of suspicion for PCP in RA patients, even those not on immunosuppressive treatment.
  • Awareness of PCP as a potential complication in RA management is essential for timely diagnosis and intervention.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
708
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
675
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
744
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.4K